Nobilis Health Corp Stock News

U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Thursday. Here are some big stocks recording gains in today’s session. Silvergate Capital Corporation (NYSE: SI) shares

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. Axcella H

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. Perfect Corp. (NYSE: PERF) shares tum

The FDA has granted emergency use authorization for Cue Health's rapid Covid test, making it the first molecular test for Covid-19 authorized for at-home use without a prescription. Ayub Khattak, Cue

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. Shares of several companies in the broader industrial space traded higher on continued hopes of softer Fed p

Cue Health, Inc. (NASDAQ:HLTH ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Lorna Williams - IR Ayub Khattak - Co-Founder, President, CEO & Chairman John Gallaghe

Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 21.82% and 19.92%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 21.82% and 19.92%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 18.18% and 11.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the

Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cue Health went public in September 2021, raising approximately $200 million in an IPO. The firm provides a COVID-19 molecular test and related software platform and is pursuing additional diagnostic

Snowflake Inc. (NYSE: SNOW) surged 17.4% to $187.18 in pre-market trading after the company reported better-than-expected Q2 sales results and issued product revenue guidance. FREYR Battery (NYSE: FRE

Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 25.2% to $0.54 in pre-market trading. Bird secured permit extensions and expanded to new U.S. cities. Minerva Neurosciences, Inc. (NASDAQ: NERV) sha

Cue Health Inc. (NASDAQ:HLTH ) Q2 2022 Results Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Lorna Williams - Investor Relations Ayub Khattak - Chairman and Chief Executive